Waystar (WAY) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 revenue reached $313.9M, up 22–22.4% year-over-year, with net income of $43.3M, a 47.9% increase from Q1 2025, and adjusted EBITDA of $135.4M, representing a 43% margin.
Over 99% of revenue is recurring, driven by subscription and volume-based fees, with net revenue retention rate at 110.5–111%.
Strong client growth with 1,433 clients contributing over $100,000 in LTM revenue, up 15% year-over-year, with about half of the growth from the Iodine acquisition.
Completed the $1.26B Iodine acquisition in October 2025, enhancing AI capabilities, expanding the client base, and contributing to revenue and client growth.
Continued platform expansion and launch of AI-powered recoupment solution, reinforcing industry leadership.
Financial highlights
Subscription revenue grew to $172.2M (up 38% YoY), and volume-based revenue to $139.5M (up 7% YoY), with subscription revenue comprising 54.9% of total.
Adjusted EBITDA margin improved to 43.1% from 42.0% year-over-year.
Net income margin improved to 13.8–14% from 11.4% YoY.
Cash flow from operations was $84.9M; unlevered free cash flow totaled $90.3M, with a 67% conversion rate from adjusted EBITDA.
Operating expenses rose to $233.4M from $191.2M YoY, with increases in R&D and G&A.
Outlook and guidance
FY 2026 revenue guidance set at $1.284B at midpoint (range: $1.274B–$1.294B), representing 17% YoY growth.
Adjusted EBITDA guidance for FY 2026 is $530M–$540M, with margin expected to remain at 42–43%.
Non-GAAP net income projected at $317M–$335M and diluted non-GAAP EPS at $1.59–$1.68 for FY 2026.
Management expects continued growth through client expansion, cross-selling, and increased adoption of AI-powered solutions.
Sufficient liquidity is anticipated for at least the next 12 months, with ongoing investments in growth and technology.
Latest events from Waystar
- Record revenue, AI innovation, and strong governance mark a transformative year.WAY
Proxy filing17 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and annual say-on-pay frequency.WAY
Proxy filing17 Apr 2026 - Record FY2025 growth, 43% Q4 EBITDA margin, and strong 2026 outlook after Iodine integration.WAY
Q4 202511 Apr 2026 - AI-powered automation streamlines healthcare payments, boosting efficiency and financial outcomes.WAY
Waystar True North Client Conference3 Feb 2026 - Q2 revenue up 20% to $234.5M, 40% EBITDA margin, and improved leverage ratios.WAY
Q2 20242 Feb 2026 - Modern, AI-powered platform drives growth, efficiency, and client wins amid rising cybersecurity focus.WAY
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 revenue up 22% to $240.1M, 40% EBITDA margin, and major debt reduction post-IPO.WAY
Q3 202416 Jan 2026 - AI-driven automation and data integration fuel growth, efficiency, and client satisfaction.WAY
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Cloud-based healthcare payment software drives growth, efficiency, and resilience in a shifting market.WAY
7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026